Log in to save to my catalogue

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1417528697

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

About this item

Full title

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Publisher

United States: Oxford University Press

Journal title

Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S125-S128

Language

English

Formats

Publication information

Publisher

United States: Oxford University Press

More information

Scope and Contents

Contents

Boceprevir and telaprevir are inhibitors and substrates of the cytochrome P450 3A4 family. With the use of these HCV protease inhibitors as part of standard therapy for chronic hepatitis C genotype 1 infection, drug—drug interactions with multiple medications being inductors, inhibitors, or substrates of cytochrome P450 3A4 can be expected. Due to...

Alternative Titles

Full title

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1417528697

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1417528697

Other Identifiers

ISSN

1058-4838

E-ISSN

1537-6591

DOI

10.1093/cid/cit299

How to access this item